| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |